Erudio Healtherudio.com
Drug
Gefitinib trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying gefitinib: LASER301. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 7 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| LASER301 NCT04248829 · Yuhan Corporation | first-line EGFR-mutated locally advanced or metastatic NSCLC | Phase 3 | 88 | 18 | Focused | Oct 31, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| FLAURA NCT02296125 · AstraZeneca DeepView → | first-line EGFR-mutated advanced non-small cell lung cancer | Phase 3 | Deep | View | |||
| IPASS NCT00322452 · AstraZeneca DeepView → | first-line advanced non-small cell lung cancer | Phase 3 | Deep | View | |||
| ADJUVANT NCT01405079 · Guangdong Association of Clinical Trials DeepView → | resected stage II–IIIA (N1–N2) EGFR-mutant NSCLC | Phase 3 | Deep | View | |||
| KEYNOTE-021 NCT02039674 · Merck Sharp & Dohme LLC StandardView → | locally advanced or metastatic non-small cell lung carcinoma | Phase 1/Phase 2 | Standard | View | |||
| ORCHARD NCT03944772 · AstraZeneca StandardView → | EGFR-mutated advanced NSCLC after first-line osimertinib | Phase 2 | Standard | View | |||
| RELAY NCT02411448 · Eli Lilly and Company FocusedView → | untreated EGFR-mutated metastatic NSCLC | Phase 3 | Focused | View | |||
| APPLE NCT02856893 · European Organisation for Research and Treatment of Cancer - EORTC FocusedView → | advanced EGFR-mutant non-small-cell lung cancer | Phase 2 | Focused | View | |||